Phase II study of 1,2,4-triglycidylurazol (TGU) previously untreated and treated patients with small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II study of 1,2,4-triglycidylurazol (TGU) previously untreated and treated patients with small cell lung cancer

Published:1987-07 Issue:7 Volume:23 Page:1031-1033
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Lund Birthe,Hansen Flemming,Hansen Mogens,Hansen Heine Høi

Publisher

Elsevier BV

Subject

Oncology

Reference9 articles.

1. Phase II study of teniposide in small cell carcinoma of the lung;Pedersen;Cancer Treat Rep,1984

2. Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer;Bork,1986

3. 1,2,4-Triglycidylurazol (TGU, NSC-332488, I.N.N.: Amaxirone): a new chemotherapeutic agent;Hilgard;Cancer Treat Rep,1984

4. Phase I trial of 1,2,4-triglycidylurazol (TGU, NSC-332488): a new tri-epoxid cytostatic agent;Hansen;Eur J Cancer Clin Oncol,1985

5. Prognostic factors in small cell lung cancer: an analysis of 874 consecutive patients;Østerlind,1986

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.;Journal of Clinical Oncology;1997-05

2. Revisiting the debate: the use of new agents in previously untreated patients with small cell lung cancer; quality versus duration of survival;Journal of Cancer Research and Clinical Oncology;1994-12

3. Strategies for new drug identification in small cell lung cancer;Lung Cancer;1993-08

4. New perspectives in lung cancer.5. New drugs in lung cancer.;Thorax;1992-03-01

5. Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.;Journal of Clinical Oncology;1992-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3